Right now, researchers simply do not know whether one mammography method is better than another other at finding life-threatening breast cancers early.
The TMIST breast cancer screening trial continues to enroll women during the COVID-19 pandemic. This article describes ways trial leaders and clinical staff are making TMIST available to women in minority communities.